AASLD Registration 8 Nov 2014 Sheraton Boston Hotel, Boston, United States
Submit new post
Thank you for posting.
Share it:

This CME/CE activity is designed for hepatologists, gastroenterologists, infectious disease specialists, primary care providers, nurses, physician assistants, and pharmacists who are involved in the screening and treatment of patients with or at risk for developing primary biliary cirrhosis (PBC) and nonalcoholic steatohepatitis (NASH).
Activity Goal

The goal of this activity is to examine current and emerging strategies for diagnosing, treating, and managing patients with PBC and NASH to ensure early diagnosis and treatment that results in improved patient outcomes.
Learning Objective(s)

Identify unmet needs in the management of primary biliary cirrhosis (PBC) and nonalcoholic steatohepatitis (NASH) and describe how novel therapeutic approaches may help overcome existing challenges.

Analyze the results of clinical trials evaluating the efficacy, safety, and tolerability of emerging therapies for the management of PBC and NASH to provide customized treatments that improve patient outcomes.